Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
April 25, 2024 5:30 AM EDTSanofi (NASDAQ: SNY) saw its shares jump 5% in premarket trading Thursday after the company posted better-than-expected business operating profit for the fiscal Q1.
The pharmaceutical company reported Q1 earnings per share (EPS) of EUR 1.78, surpassing the consensus estimate of EUR 0.93. Revenue for the quarter stood at EUR 10.46... More
